Related by context. All words. (Click for frequent words.) 70 therapeutic monoclonal antibodies 70 antisense drug 69 anticancer therapeutics 68 MEK inhibitors 68 siRNA therapeutics 68 antisense 68 humanized monoclonal antibodies 67 novel RNAi therapeutics 67 humanized antibodies 67 novel antibody therapeutics 67 LNP formulations 67 targeting CD# 67 RNAi therapeutic 67 microRNA therapeutics 66 therapeutic antibodies 66 Nanobodies ® 66 short interfering RNA 66 cancer immunotherapies 66 Nanobody ® 66 siRNA compounds 66 antisense oligonucleotides 66 synthetic retinoid 66 oncolytic 66 preclinical compounds 66 Locked Nucleic Acid LNA 66 small molecule inhibitors 65 anticancer agents 65 Nanobodies 65 SARMs 65 monoclonal antibodies 65 lentiviral vector 65 novel antiviral therapeutics 65 miRNA therapeutics 65 anticancer compounds 65 recombinant antibodies 65 peptide antigens 65 Nanobody 65 proprietary PEGylation 64 anticancer therapies 64 NovaBay Aganocide compounds 64 antiviral therapies 64 aptamer therapeutics 64 Locked Nucleic Acid 64 monoclonal antibody therapeutics 64 RNAi therapeutic targeting 64 pharmacological chaperone 64 LEX System 64 BCR ABL inhibitors 64 selective inhibitors 64 polymerase inhibitors 64 Stapled Peptide 64 small molecule PEGylation 64 antibody therapeutics 64 JAK1 64 JAK inhibitors 64 small molecule 64 OncoVEX 64 fusion proteins 64 HuLuc# 64 protein kinase inhibitor 64 proteasome inhibitors 64 ALN VSP 64 Isis antisense 64 antisense inhibitors 64 IAP inhibitors 63 ddRNAi 63 AEG# 63 tiapamil 63 antiviral compounds 63 XmAb 63 CobaCyte 63 shRNA libraries 63 immunotherapeutics 63 siRNA therapeutic 63 MEK inhibitor 63 intracellular signaling pathways 63 NuMimetic TM 63 therapeutic antibody 63 CCR9 antagonist 63 Nanobodies R 63 Fleximer 63 transfection reagents 63 kinase inhibitors 63 GPR# agonist 63 PARP inhibitors 63 affinity antibodies 63 antagomirs 63 nanomedicines 63 Mipomersen 63 prostone 63 therapeutic monoclonal antibody 63 dAbs 63 NTDDS 63 MAbs 63 humanized antibody 63 lipid nanoparticle 63 stable nucleic acid 63 PEGylated 63 Dicer Substrate Technology 63 histone deacetylase HDAC inhibitors 63 novel peptides 63 selective androgen receptor modulators 63 DsiRNA 63 FGFR 63 epothilone 63 SMaRT ™ 63 bioinformatic approaches 62 antisense compounds 62 epothilones 62 Phylomer ® 62 LentiVector technology 62 neuroprotective properties 62 PI3K inhibitor 62 Smac mimetics 62 XmAb# 62 ALN TTR 62 hedgehog pathway 62 RNA antagonists 62 Ibis T# TM 62 JAK3 62 novel peptide 62 covalent drugs 62 Hsp# inhibition 62 immunotoxins 62 anti CD3 62 rxRNA compounds 62 commercialize microRNA therapeutics 62 miR #a [002] 62 exon skipping 62 AtuRNAi 62 nucleoside analogues 62 rxRNA 62 POTELLIGENT ® 62 UltiMAb 62 RNA therapeutics 62 synthetic peptides 62 SNALP 62 Tyrima 62 renin inhibitors 62 CYT# potent vascular disrupting 62 AAV vectors 62 NEUGENE R 62 immunotherapies 62 Squalamine 62 lentiviral vectors 62 Symadex 62 MVA BN R 62 mAbs 62 TLR9 agonists 62 DNA plasmids 62 druggable targets 62 OGeS 62 SERMs 62 anionic backbone 62 Adnectin 62 HDAC inhibition 62 predictive biomarkers 62 CTLA4 Ig 62 phage display 62 Fleximer R 62 ALN PCS 62 oncolytic virus 62 molecularly targeted 62 kidney urologic 62 chimeric antibodies 61 ZFP technology 61 HepDirect 61 selective inhibition 61 Affibody ® molecules 61 lipid nanoparticles 61 generation antisense 61 Fc fusion protein 61 chemically modified siRNA 61 Novosom 61 Hsp# inhibitors 61 deacetylase inhibitors 61 TLR Therapeutics 61 Scancell 61 CORT # 61 VEGF receptor 61 anticoagulant reversing agent 61 PROfusion 61 ENMD # 61 biologic therapeutics 61 selective kinase inhibitor 61 Wnt signaling pathway 61 recombinant adeno associated 61 CCX# 61 HDAC inhibitors 61 small molecule defensin 61 Preclinical studies suggest 61 siRNA delivery 61 protein therapeutics 61 antibody fragment 61 liposomal delivery 61 zinc finger nuclease 61 iPSC technology 61 drug conjugate 61 ImmunoGen TAP technology 61 HCV protease inhibitors 61 Hedgehog signaling pathway 61 Curaxin 61 Phylomer 61 vaccine GRNVAC1 61 molecular biomarkers 61 prophylactic vaccines 61 antiangiogenesis therapies 61 virus AAV 61 HCV protease inhibitor 61 investigational compounds 61 Xencor XmAb 61 Potelligent 61 prodrugs 61 HuCAL antibody 61 mGluR4 61 HTS assay 61 mertansine 61 romazarit 61 URG# 61 histone deacetylase HDAC 61 small interfering RNA 61 small molecule activators 61 Curaxins 61 human antibody therapeutics 61 PluriCells TM 61 nitric oxide donating 61 GAP #B# 60 FoldRx 60 single stranded oligonucleotides 60 diagnostic biomarkers 60 TRAIL receptor antibodies 60 Stemgent 60 Affinitak 60 novel immunomodulatory 60 oncolytic viruses 60 histone deacetylase inhibitors 60 Hedgehog pathway 60 anti CD# antibodies 60 MitoQ 60 tkRNAi technology 60 small molecule agonists 60 HepDirect R 60 MTP inhibitor 60 otelixizumab 60 nucleoside analogs 60 vascular disrupting agents 60 Viprovex TM 60 CXCR4 receptor 60 commercialize microRNA 60 oral prodrug 60 Vidofludimus 60 mda 7 60 biologic therapies 60 Aurora kinase 60 THR beta agonist 60 synthetic cannabinoid compounds 60 ESBA# 60 proteasome inhibitor 60 ZFNs 60 AKT inhibitor 60 antibacterial compounds 60 inhibit viral replication 60 proprietary LNA 60 HCV protease 60 oligonucleotide therapeutics 60 DiLA2 60 apoptotic pathway 60 commercialize deforolimus 60 Cylene 60 JAK2 inhibitor 60 Vaccinex 60 immunological diseases 60 GRNVAC1 60 adrenergic regulation 60 targeting PCSK9 60 PDE4 inhibitor 60 Syncria 60 ALN TTR# 60 AGS PSCA 60 small molecule modulators 60 peptide therapeutics 60 gastro intestinal inflammation 60 monoclonal antibody MAb 60 GlycoPEGylation TM technologies 60 NEUGENE 60 NexACT 60 adenoviral 60 OXIGON TM 60 inhibit replication 60 faropenem 60 POTELLIGENT R 60 CBLC# 60 Epothilones 60 commercializing anti infective 60 antiviral therapeutics 60 gamma secretase inhibitors 60 Smac mimetic 60 integrase inhibitor 60 tranilast 60 MMP inhibitors 60 orally bioavailable 60 chemotherapeutics 60 humanized anti 60 cilengitide 60 PCSK9 60 aptamers 60 ErbB3 HER3 60 therapeutics 60 orphan GPCRs 60 NNRTIs 60 BiTE 60 Adenosine Therapeutics 60 P#X# 60 Monoclonal antibodies 60 ribonuclease 60 Tarvacin TM 60 biased ligand 60 aptamer 60 boron chemistry 60 RNAi therapeutics 60 investigational humanized monoclonal antibody 60 advanced polymer conjugate 60 FLT3 60 Targeted Chemotherapy 60 optical biosensors 60 TLR agonists 60 hormone gastrin 60 engineered proteases 60 Medarex UltiMAb R 60 AVI NEUGENE 60 Vaxfectin 60 vivo validation 60 CD# monoclonal antibody 60 BRAF kinase 60 nucleoside 60 Olaparib 60 interferon lambda 60 Pervasis 60 Janus kinase 60 Therapeutic antibodies 60 humanized monoclonal antibody 60 cancer immunotherapy 60 rheumatoid arthritis multiple sclerosis 60 antisense inhibition 60 PDGF receptor 60 Anticalin 60 monoclonal antibodies MAbs 60 AKIP 60 nanoviricides 60 isoform selective 60 OMP #M# 60 MediVas 60 HQK 60 JAK inhibitor 60 systemic RNAi 59 OncoMed 59 RNAi 59 Viamet 59 NNR Therapeutics 59 Quark Biotech Inc. 59 mRNA antagonists 59 UsiRNAs 59 #ME# 59 M2 subunit 59 telomerase inhibitor 59 Alnylam RNAi 59 nucleoside analog 59 AMPK activators 59 VentiRx 59 MDRNA proprietary 59 tyrosine kinase inhibitor 59 DNAi 59 cellular pathways 59 rxRNA ™ compounds 59 GlycArt 59 Anticalins R 59 novel therapeutic antibodies 59 HSP# inhibitor 59 imatinib Gleevec 59 adenovector 59 Ii protein 59 small molecule thrombopoietin 59 oncology therapeutics 59 siRNA binds 59 Selective Electrochemical Tumor Ablation 59 G Protein Coupled 59 Nektar PEGylation technology 59 enzyme inhibitor 59 RECOTHROM R 59 Darapladib 59 selective immunoproteasome inhibitor 59 A3 adenosine receptor 59 polyclonal antibodies 59 Sphingomab 59 GPCR targets 59 antibody 59 recombinant protein 59 ssRNAi 59 antibody therapies 59 biased ligands 59 dSLIM 59 CB2 receptor 59 proprietary MSCRAMM ® 59 SGLT2 inhibitors 59 Nautilus Biotech 59 Litx 59 cancer therapeutics 59 Aviptadil 59 Crucell PER.C6 ® 59 YONDELIS 59 metalloenzymes 59 Fibroblast Growth Factor Receptor 59 IAP inhibitor 59 LentiVector 59 ZFP Therapeutics 59 metaglidasen 59 undruggable targets 59 small interfering RNAs 59 commercialize apixaban 59 HGS ETR1 mapatumumab 59 immunotoxin 59 cyclophilin inhibitors 59 cytotoxin 59 human monoclonal antibody 59 enzyme inhibitors 59 cyclin dependent kinases 59 FOLOTYN ® 59 ImmunoGen maytansinoid TAP 59 nucleoside analogue 59 VaxImmune 59 Chemetics R 59 SMARTICLES ® 59 KL4 Surfactant 59 endogenous ligands 59 MT#/MEDI-# 59 Survivin antagonist 59 investigational therapies 59 TKM ApoB 59 Factor VIIa 59 IMiDs 59 Excaliard 59 Nasdaq HALO biopharmaceutical 59 proprietary phage display 59 hematological cancers 59 CD# CEA 59 PI3 kinase 59 DepoVax ™ 59 antisense inhibitor 59 generation NEUGENE antisense 59 OHR/AVR# 59 Insegia 59 Tekmira SNALP technology 59 chemical entities NCEs 59 SNALP technology 59 Liprotamase 59 lipid particles 59 carbohydrate polymers 59 vaccines oncolytic virus 59 siRNA 59 InterfeRx 59 Transdel TM 59 nicotinic alpha 7 59 viral vector 59 Exelixis compounds 59 protein misfolding 59 TLR9 agonist 59 resolvins 59 Relivar 59 identify protein biomarkers 59 C5aR 59 Anticalins 59 Sangamo ZFP technology 59 PTP 1B 59 RNA interference 59 geldanamycin 59 Salmonella vector 59 ACTCellerate 59 RNAi compounds 59 GPR# agonists 59 inhibit metastasis 59 oral antiviral 59 regenerative medicine therapies 59 selective orally bioavailable 59 Azedra 59 sd rxRNA compounds 59 Gleevec resistant 59 engineered RAP peptides 59 modulator SERM 59 CompoZr 59 antibody fragment therapeutics 59 siRNA sequences 59 candidate deforolimus 59 investigational monoclonal antibody 59 Guanilib 59 Regado 59 recombinant subunit vaccine 59 ZFPs 58 commercializing aptamer therapeutics 58 Lixivaptan 58 lipid mediators 58 RECOTHROM ® 58 multi kinase inhibitor 58 preclinically 58 TGR5 58 ZFP TF 58 ParAllele 58 volociximab 58 CCR3 58 AAV vector 58 anti CD3 monoclonal 58 allosteric modulator 58 telomerase therapeutic 58 catalytic antioxidant compounds 58 HDAC inhibitor 58 bispecific antibody 58 RNA silencing 58 HIV integrase inhibitors 58 Homspera 58 AvalonRx R 58 BioSilicon TM 58 miR #b [002] 58 intracellular protein 58 TRAIL receptor 58 CRTH2 58 Potelligent Technology 58 monoclonals 58 synthetic siRNA 58 CD# antibody [001] 58 Epitomics 58 polyketides 58 sphingolipid 58 Abiraterone acetate 58 ErbB3 58 ImmunoGen Tumor Activated Prodrug 58 stem cell therapeutics 58 Listeria vaccine 58 DECIPHER R 58 investigational pan BCR 58 antisense therapeutics 58 phage display technology 58 potent inhibitors 58 eligen R technology 58 ProNAi 58 theranostic 58 antisense oligonucleotide 58 preclinical 58 nifurtimox 58 RNA antagonist 58 DGAT1 inhibitors 58 siRNA constructs 58 meganucleases 58 Amplimexon 58 recombinant polyclonal antibodies 58 ISIS # 58 ZFP Therapeutic 58 develop selective androgen 58 PKM2 58 Santaris 58 antibody humanization 58 Onconase 58 Curaxin CBLC# 58 DiscoveRx 58 Teplizumab 58 tests miRview TM 58 ATL# [002] 58 myelofibrosis polycythemia vera 58 Zacharon 58 Micromet BiTE 58 staphylococcal vaccine 58 platinum chemotherapeutic 58 monoclonal antibody 58 NS5b 58 TLR8 58 Protein Kinase C 58 MAbs targeting 58 mucosal vaccines 58 Sym# 58 Dyax phage display 58 siRNAs targeting 58 siRNA molecules 58 myeloproliferative disorders 58 BRAF inhibitor 58 Chrysalin 58 monoclonal antibody mAb 58 AMPAKINE 58 acetylcholinesterase AChE 58 Bezielle 58 PEGylation 58 histone methyltransferases HMTs 58 Aurora kinase inhibitor 58 Regulus Therapeutics 58 ASONEP 58 EGFR HER 58 sd rxRNA 58 anti angiogenesis 58 anti infective treatments 58 renin inhibitor 58 patented Bioral 58 Metallophile ™ Technology 58 Affibody 58 plasmid DNA pDNA 58 ocular diseases 58 JAK#/JAK# 58 COMPLEGENT TM Technologies 58 immunotherapeutic approaches 58 nonviral 58 Profectus BioSciences 58 molecular chaperone regulation 58 Charlesson 58 teplizumab 58 deCODE chemistry 58 SGLT inhibitors 58 EyeGate 58 ZFP TFs 58 ZFN TM 58 MAb 58 adenovirus vector 58 EphA2 58 dAb 58 KL4 surfactant 58 MEK ERK 58 Panzem 58 personalized immunotherapy 58 gamma secretase inhibitor 58 GeneICE 58 HSP# inhibitors 58 encapsulates siRNAs 58 immunotherapeutic 58 fatty acid amide hydrolase 58 Vegenics 58 Alnylam Pharmaceuticals Nasdaq ALNY 58 drug conjugates ADCs 58 peroxisome proliferator activated 58 KineMed 58 Cobalamin 58 XmAb ™ 58 proprietary Dicer Substrate Technology 58 EndoTAG TM 58 kinase inhibitor 58 multiplexed assays 58 Captisol 58 transgenic rats 58 radezolid 58 JAK2 inhibitors 58 liposomal 58 therapeutic peptide 58 selective antagonists 58 Zolinza 58 Viprovex R 58 ADCC enhanced 58 Human cl 58 antibody MAb 58 oncology indications 58 transcutaneous immunization TCI 58 ArQule Kinase Inhibitor Platform 58 Bioral ® 58 VEGF inhibitors 58 integrative pharmacology 58 sodium glucose transporter 58 SOD1 58 small molecule glucokinase 58 vinca alkaloids 58 Celator 58 PER.C6 ® cell 58 phosphate S1P 58 anti angiogenic agents 58 MVA BN 58 alpha interferon 58 EndoTAG 58 lentiviral 58 CXCR4 58 p# inhibitors 58 eIF 4E 58 cell signaling pathways 58 RNA interference RNAi therapeutics 58 Cellzome 58 Protexia R 58 CEQ# 58 Anaphore 58 DepoVax TM 58 GelSite R polymer 58 Tekmira lipid nanoparticle 58 PEGylation technology 58 liposomal formulations 58 DNA methyltransferases 58 monoclonal antibodies mAbs 58 immune modulatory 58 RNAi gene silencing 58 poly ADP ribose polymerase 58 adenoviral vectors 58 Cerashield 58 SuperAntibody 58 buccal delivery 58 Tarvacin 58 lipidoid 57 nanocarriers 57 immunomodulator 57 stapled peptides 57 SIMPLE Antibody TM 57 dependent cellular cytotoxicity 57 VitiGam 57 oral JAK1 57 delta isoform 57 reverse vaccinology 57 Heptares 57 Biopump 57 product platforms AZX# 57 effector functions 57 GVAX cancer 57 siRNAs 57 agonist compounds 57 JAK kinases 57 epigenetic therapies 57 multitargeted 57 Daclizumab 57 VeraTag 57 PI3K/mTOR 57 NPM1 57 Virulizin ® 57 Duchenne muscular dystrophy DMD 57 ETBs 57 JAK2 57 non nucleoside HCV 57 viral vectors 57 PDE# 57 eTag assays 57 SMARTICLES 57 IgG1 antibody 57 CD# antibodies 57 non nucleoside 57 entinostat 57 peptidomimetic 57 NXL# 57 pan HDAC inhibitor 57 Betrixaban 57 SAR# [002] 57 HIV protease inhibitors 57 immunoregulation 57 anti angiogenic agent 57 Antisense 57 delivered RNAi therapeutic 57 immatics 57 mTOR inhibitors 57 oncolytic virus therapies 57 XL# XL# XL# XL# 57 ALN HTT 57 Quark Biotech 57 topical formulations 57 developing TB4 57 angiogenesis inhibitor 57 acne impetigo 57 Avila Therapeutics 57 tkRNAi 57 Bioral 57 Revimmune 57 Thiovir 57 Archexin 57 short hairpin RNAs 57 Nutra Pharma wholly owned 57 hemorrhagic fever viruses 57 Enzo Therapeutics 57 Transfection Reagent 57 tumor antigens 57 delta opioid receptor 57 humanized monoclonal 57 Alnylam #x# 57 Transfluor 57 ALV# 57 NF kappa B 57 Trophos 57 DGAT 57 LY# [003] 57 Galenea 57 MicroDose 57 Bryostatin 57 immune modulators 57 OncoVEX GM CSF 57 Affitech AS 57 molecular profiling 57 DiLA 2 57 MyVax R 57 HGS# 57 topoisomerase 57 c Raf kinase 57 HuCAL 57 Pimavanserin 57 tubulin inhibitors 57 selective androgen receptor modulator 57 Antigen Express 57 SPC# [001] 57 protein tyrosine phosphatases 57 neuronal nicotinic receptors NNRs 57 Symphogen 57 generation nucleoside analog 57 Dapagliflozin 57 potently inhibit 57 delay bone metastases 57 CR# vcMMAE 57 neurotrophic factor 57 molecular assays 57 HyperAcute 57 Archemix Corp. 57 IL# PE 57 subtype selective 57 liposomal formulation 57 PDE4 inhibitors 57 dacetuzumab 57 PharmFilm ® 57 nucleotide analogs 57 RONDEL ™ 57 Enhanze Technology 57 DOS# 57 Chemokine Receptor 57 EGF receptor 57 recombinant fusion 57 E2F Decoy 57 sodium glucose cotransporter 57 factor receptor FGFR 57 cediranib 57 mAb 57 endostatin 57 MLN# 57 intranasal delivery 57 DispersinB ® 57 Tofacitinib 57 GVAX ® 57 microRNA miRNA 57 synthetic peptide 57 IMA# 57 immunomodulators 57 Tarvacin Anti Viral 57 splice variants 57 HepDirect prodrug 57 Nasdaq MITI biopharmaceutical 57 multiplex assay 57 Septin9 biomarker 57 Cintredekin Besudotox 57 ACTCellerate ™ 57 trans splicing 57 attach auristatin 57 Anticalins ® 57 micro RNA 57 CDP# 57 ImmunoVEX HSV2 57 virosome 57 molecular imaging radiopharmaceuticals 57 Endotis 57 Kleanthis G. Xanthopoulos Ph.D. 57 VEGF Trap 57 molecular mimicry 57 Janus Kinase 57 enveloped viruses 57 JAK2 kinase 57 Nasdaq IMGN biotechnology 57 ProMune 57 BioVant 57 CYT# novel 57 DiaKine 57 Vandetanib 57 RONDEL TM 57 cleavable linker 57 Cerashield ™ 57 PER.C6 57 oligonucleotides 57 glycosylated 57 SECTA therapy 57 CB2 selective 57 PARP inhibitor 57 recombinant vaccines 57 Genetronics 57 IMC #B 57 LymphoStat B belimumab 57 protein tyrosine phosphatase 1B 57 Alfacell proprietary ribonuclease 57 CTLA 4 57 chemotherapeutic drugs 57 TH# cells 57 HyACT 57 rxRNA TM compounds 57 cytolytic 57 InterfeRx TM 57 novel anti infective 57 Resten NG 57 novel VDA molecule 57 anticancer agent 57 enzastaurin 57 biodegradable nanoparticles 57 Adnectins 57 PNP inhibitor 57 TCAD therapy 57 Ibis T# 57 Monoclonal antibody 57 vaccine adjuvants 57 genetic biomarkers 57 ANGPTL4 57 Davanat 57 antigen sparing 57 Xanafide 57 Thiarabine 57 DiLA2 platform 57 ZFN technology 57 cytotoxic agents 57 integrin receptors 57 TLR9 57 CDDO Im 57 ADI PEG 57 oxidative stress inducer 57 Cx# [002] 57 Spiegelmers R 57 XmAb ® 57 Aegera 57 Gamma secretase 57 oral Janus kinase 57 S#P# 57 ImmunGene 57 polymer conjugate technology 57 ospemifene 57 VisEn Medical 57 NFkB 57 thiazolides 57 BRAF inhibitors 57 Factor Receptor 57 adenosine A2A 57 HuCAL R 57 MYDICAR ® 57 OncoVex 57 targeted radiotherapeutic 57 fusion protein 57 orally administered inhibitor 57 5 HT6 57 NS#/#A protease 57 Onalta 57 iPSC 57 tumor hypoxia 57 Intellikine 57 Spiegelmers ® 57 daclizumab 57 selective kinase inhibitors 57 theranostics 57 Poly ICLC 57 Transdel ™ 57 Viral Immunotherapy platform 57 cHTS 57 validating biomarkers 57 chemokine 57 beta secretase inhibitors 57 Isogenica 57 P#X# antagonist 56 targeted covalent 56 LHRH antagonists 56 ActivX 56 Aptamer 56 Hsp# inhibitor 56 Provectus Pharmaceuticals specializes 56 CB1 antagonists 56 Cyclosert 56 Dacetuzumab 56 Ridaforolimus 56 kallikrein 56 microRNA sequences 56 Micromet proprietary BiTE 56 triterpenoids 56 RECEPTORS 56 peptibody 56 taxol 56 rFVIIIFc 56 bexarotene 56 dexpramipexole 56 virulence genes 56 Tr DNA 56 ATL# [001] 56 inhibiting tumor 56 diagnostic assays 56 EGFR inhibitors 56 transdermal spray 56 PI3K inhibitors 56 VRX# [002] 56 purinergic receptors P#X# 56 Lentigen 56 Staccato nicotine technology 56 Cytolin R 56 lapatinib Tykerb 56 chemotherapeutic agents 56 Kosan dependence 56 Cetrorelix 56 Civacir 56 phosphatidylserine PS targeting 56 DCVax R 56 anti CD# monoclonal 56 HDAC 56 IIB ActRIIB 56 RGB # 56 T#I [002] 56 maytansinoid 56 Aplidin 56 anticancer drugs 56 miRagen 56 BioSilicon 56 Debio